Gene · 5698
Papers4,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a novel chemotherapy benefit index for patients with advanced ovarian cancer based on Bayesian network analysis. | PLoS One | 2025 | 40424327 | PubTator, text mining | PubMed |
| Immunoproteasome-specific Subunit Alterations as a Potential Therapeutic Target for Mitochondriopathies. | J Mol Biol | 2025 | 40414596 | PubTator, text mining | PubMed |
| Targeting intracellular LMP2 with costimulatory signal-armed antibody-like TCR T cells. | JCI Insight | 2025 | 40401520 | PubTator, text mining | PubMed |
| From induced pluripotent stem cell (iPSC) to universal immune cells: literature review of advances in a new generation of tumor therapies. | Transl Cancer Res | 2025 | 40386273 | PubTator, text mining | PubMed |
| Recent advances in nuclear actin research. | Nucleus | 2025 | 40320716 | PubTator, text mining | PubMed |
| Influence of PSMB6 and PSMB9 Genetic Polymorphisms on Bortezomib-Based Therapy Response in Newly Diagnosed Multiple Myeloma. | Cureus | 2025 | 40271316 | PubTator, text mining | PubMed |
| Catalytic proteasome subunits are heterogeneously active in human platelets with β1i playing a role in signaling and granule release. | Biochim Biophys Acta Mol Cell Res | 2025 | 40246178 | PubTator, text mining | PubMed |
| Immunoproteasome subunits are novel signatures for predicting efficacy of immunotherapy in muscle invasive bladder cancer. | J Transl Med | 2025 | 40012053 | PubTator, text mining | PubMed |
| Vaccine-Based Immunotherapy for Oropharyngeal and Nasopharyngeal Cancers. | J Clin Med | 2025 | 40004705 | PubTator, text mining | PubMed |
| Near-Basis-Set-Limit Double-Hybrid DFT Energies with Exceptionally Low Computational Costs. | J Phys Chem Lett | 2025 | 39977113 | PubTator, text mining | PubMed |
| A druggable targets discovery strategy for diseases (DTDS): Taking Rheumatoid arthritis as a case. | Int Immunopharmacol | 2025 | 39904046 | PubTator, text mining | PubMed |
| Epstein-Barr virus-infected nasopharyngeal carcinoma therapeutics: oncoprotein targets and clinical implications. | Med Oncol | 2025 | 39888474 | PubTator, text mining | PubMed |
| Specific Immune Responses and Oncolytic Effects Induced by EBV LMP2A-Armed Modified Ankara-Vaccinia Virus Vectored Vaccines in Nasopharyngeal Cancer. | Pharmaceutics | 2025 | 39861700 | PubTator, text mining | PubMed |
| Identifying potential mechanism and targets for treatment of tertiary lymphoid structure in lupus nephritis based on bioinformatics analysis. | Int Immunopharmacol | 2025 | 39854874 | PubTator, text mining | PubMed |
| Screening, identification and functional validation of Microcystin-LR direct binding target proteins based on thermal proteomics profiling. | Sci Total Environ | 2025 | 39675292 | PubTator, text mining | PubMed |
| Fluorinated polyethyleneimine vectors with serum resistance and adjuvant effect to deliver LMP2 mRNA vaccine for nasopharyngeal carcinoma therapy. | Acta Biomater | 2025 | 39657865 | PubTator, text mining | PubMed |
| DHDH-mediated D-xylose metabolism induces immune evasion in triple-negative breast cancer. | Med | 2025 | 39520982 | PubTator, text mining | PubMed |
| Identification and Validation of an Invasion-Related Disease-Free Survival Prognostic Model for Tongue Squamous Cell Carcinoma. | Oncology | 2025 | 39307124 | PubTator, text mining | PubMed |
| Exploring the influence of (n - 1)d subvalence correlation and of spin-orbit coupling on chalcogen bonding. | Phys Chem Chem Phys | 2025 | 39137017 | PubTator, text mining | PubMed |
| Integration of Graph Neural Networks and multi-omics analysis identify the predictive factor and key gene for immunotherapy response and prognosis of bladder cancer. | J Transl Med | 2024 | 39716185 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5698/papers?page=6